Lamdong Pharmaceutical Joint Stock Company reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported revenue was VND 33,767.43 million compared to VND 59,205.5 million a year ago. Net loss was VND 5,395.32 million compared to VND 7,458.15 million a year ago. Basic loss per share from continuing operations was VND 425 compared to VND 587 a year ago. Diluted loss per share from continuing operations was VND 425 compared to VND 587 a year ago.
For the nine months, revenue was VND 119,502.78 million compared to VND 178,841.8 million a year ago. Net loss was VND 16,342.8 million compared to VND 20,620.88 million a year ago. Basic loss per share from continuing operations was VND 1,287 compared to VND 1,623 a year ago. Diluted loss per share from continuing operations was VND 1,287 compared to VND 1,623 a year ago.